Thursday, October 12, 2023 5:31:07 AM
On the other hand, I lost a good chuck of change on RLFTF (small Swiss based biotech). RLFTF had a lot of pumping by the doctor doing the trial and suckered me in. They too were seeking EUA for covid. In the end the FDA essentially rejected their drug.
I've concluded that it is a very low probability trade to think that the FDA will approve a drug from a small foreign country..... and that includes Canada. IMO, MF has run out of tricks, so he has invented another one to lure in new investors. Their only real source of cash inflow is dilution, so I'm reasonably sure that we'll see a devastating r/s in 2024 (2025 at the latest). But I will continue to watch this stock in case there is a new, major turn of events. But I have very little faith now.
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM